GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Predilife SA (XPAR:ALPRE) » Definitions » Change In Payables And Accrued Expense

Predilife (XPAR:ALPRE) Change In Payables And Accrued Expense : €0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Predilife Change In Payables And Accrued Expense?

Predilife's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2023 was €0.00 Mil. It means Predilife's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Jun. 2023 .

Predilife's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2022 was €0.00 Mil. It means Predilife's Accounts Payable & Accrued Expense stayed the same from Dec. 2021 to Dec. 2022 .


Predilife Change In Payables And Accrued Expense Historical Data

The historical data trend for Predilife's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predilife Change In Payables And Accrued Expense Chart

Predilife Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Predilife Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Predilife Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Predilife Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Predilife's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Predilife (XPAR:ALPRE) Business Description

Industry
Traded in Other Exchanges
N/A
Address
114 rue Edouard Vaillant Espace Maurice Tubiana, Villejuif, Paris, FRA, 94800
Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Predilife (XPAR:ALPRE) Headlines

No Headlines